Fennec board member Raykov retiring; board reduced to 5 directors

FENNEC PHARMACEUTICALS INC.

Rostislav Raykov notified company on Apr 27, 2026, of retirement from Board.
Will not stand for re-election at 2026 annual meeting; term ends after meeting.
Departure not due to any disagreement with company on operations or policies.
Board size reduced from 6 to 5 directors effective after annual meeting.
No board vacancies expected following the meeting and Raykov's departure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Rostislav Raykov

Board member

FENC · FENNEC PHARMACEUTICALS INC.

Filed: April 28, 2026, 7:59 PM ET

On April 27, 2026, Rostislav Raykov notified Fennec Pharmaceuticals Inc. (the "Company") of his desire to retire from the Company's Board of Directors (the "Board") and that he will not stand for re-election at the Company's 2026 annual meeting of shareholders (the "Annual Meeting").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rostislav Raykov departed as Board member at FENNEC PHARMACEUTICALS INC..

Action: retire
Role: Board member

Exact text from the filing

On April 27, 2026, Rostislav Raykov notified Fennec Pharmaceuticals Inc. (the "Company") of his desire to retire from the Company's Board of Directors (the "Board") and that he will not stand for re-election at the Company's 2026 annual meeting of shareholders (the "Annual Meeting").

View on SEC.gov

FENNEC PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001104659-26-050433

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.